纤维蛋白原在创伤性大失血救治中的研究进展  

The Development Fibrinogen in the Treatment of Massive Traumatic Hemorrhage

作　　者：尚玮 汪德清[1] SHANG Wei;WANG Deqing(Department of Transfusion Medicine,The First Medical Center of Chinese PLA General Hospital,Beijing 100853)

机构地区：[1]解放军总医院第一医学中心输血医学科,北京100853

出　　处：《临床输血与检验》2024年第2期274-281,共8页Journal of Clinical Transfusion and Laboratory Medicine

基　　金：“十三五”军事重大专项的子项目(No.BWS16J006)资助。

摘　　要：纤维蛋白原是机体血液循环中浓度最高的凝血蛋白质,在创伤性大失血的救治过程中,纤维蛋白原不仅作为主要止血成分发挥着迅速止血的作用,越来越多的证据显示其对机体的炎症免疫的靶细胞及抗微生物感染过程均发挥着重要的调节作用,本文拟从纤维蛋白原对急性创伤性大失血早、晚期生存率影响的角度对其多重作用进行综述,旨在为早期足量开展纤维蛋白原替代治疗提供更多理论支持。Fibrinogen is a coagulation protein with the highest concentration in the blood circulation.During the treatment of massive traumatic hemorrhage,more and more evidence showed that fibrinogen played a key role not only as the main hemostatic component,but also as a regulator in inflammatory immunity and the anti-microbial infection.This article provides a brief overview of the multiple function of fibrinogen in the treatment of massive traumatic hemorrhage from the prospective of its influence on the early and late mortality,aiming to provide more theoretical supports to the early and sufficient fibrinogen replacement.

关 键 词：纤维蛋白原 血小板 创伤性大失血 创伤性内皮病 脓毒症 

分 类 号：R457[医药卫生—治疗学]